Weighted Average Number of Shares Outstanding, Basic of Celldex Therapeutics, Inc. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Celldex Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • Celldex Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 66,422, a 3.1% increase year-over-year.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 66,422, a 3.1% increase from 2024.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 64,395.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 48,449,000.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Celldex Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 66,422 +2,027 +3.1% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 66,420 +126 +0.19% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 66,392 +373 +0.56% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 66,383 +7,512 +13% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 64,395 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 66,294 +19,033 +40% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 66,019 +18,766 +40% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 58,871 +11,657 +25% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 48,449 +1,561 +3.3% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 47,261 +345 +0.74% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 47,253 +494 +1.1% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 47,214 +475 +1% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 46,888 +4,018 +9.4% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 46,916 -45,406,084 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 46,759 -39,569,241 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 46,739 -39,567,261 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 42,870 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 45,453,000* 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 39,616,000* 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 39,614,000* 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2012 50,145,000* +18,098,000 01 Jan 2012 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q3 2011 44,136,000* +12,214,000 01 Jul 2011 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 37,463,000* +5,648,000 01 Apr 2011 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 32,047,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
Q3 2010 31,922,000 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 31,815,000 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011 2011 Q2

Celldex Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 66,422 +2,027 +3.1% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 64,395 -48,384,605 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 48,449,000* +48,402,112 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 46,888 +4,018 +9.4% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 42,870 +13,230 +45% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 29,640 +15,133 +104% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 14,507 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2011 39,501,000* +7,633,000 01 Jan 2011 31 Dec 2011 10-K 08 Mar 2012 2011 FY
2010 31,868,000 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.